Roles of STAT3 in leukemia (Review)

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Leukemia is a common hematopoietic malignancy affecting children and adults, with increasing incidence rates globally.
• Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in cell growth and survival.
• Abnormal STAT3 activation is increasingly implicated in the pathogenesis of various cancers, including leukemia.

Purpose of the Study:

• To review the multifaceted roles of STAT3 in leukemia.
• To elucidate STAT3's involvement in leukemia cell proliferation, differentiation, and apoptosis.
• To highlight STAT3 as a potential therapeutic target for leukemia treatment.

Main Methods:

• Comprehensive literature review of studies investigating STAT3 in leukemia.
• Analysis of STAT3's function in key cellular processes relevant to leukemia.
• Examination of evidence linking STAT3 to leukemia pathogenesis and clinical outcomes.

Main Results:

• Aberrant STAT3 activation is a common feature in leukemia development.
• STAT3 influences critical pathways regulating leukemia cell proliferation, survival, and resistance to apoptosis.
• The role of STAT3 in leukemia diagnosis and prognosis is under active investigation.

Conclusions:

• STAT3 is a significant factor in leukemia pathogenesis, impacting cell proliferation, differentiation, and apoptosis.
• Targeting STAT3 may offer novel therapeutic strategies for leukemia.
• Further research is warranted to fully understand STAT3's clinical utility in leukemia management.